Researching therapies for gastrointestinal (GI) diseases

Researching therapies for gastrointestinal (GI) diseasesResearching therapies for gastrointestinal (GI) diseasesResearching therapies for gastrointestinal (GI) diseases

When your body already holds the answer

Contact Us

Researching therapies for gastrointestinal (GI) diseases

Researching therapies for gastrointestinal (GI) diseasesResearching therapies for gastrointestinal (GI) diseasesResearching therapies for gastrointestinal (GI) diseases

When your body already holds the answer

Contact Us

About Us

What we do

We are a research based biopharmaceutical company focused on discovering therapies for patients with liver and gastrointestinal (GI) diseases. Our most advanced research focuses on understanding the farnesoid X receptor (FXR), which is central to modulating liver and GI diseases

Our Approach

Progress Forward

In January 2020, only nine months after having set up the research lab, rapid progress has been made in discovering and characterizing distinct chemical entities towards a novel therapeutic target for FXR which is central to modulating liver and GI diseases. During this first phase of the research, we have solved a crystallographic structure of the protein targeted by our team. Additionally, Revitocrine established a selective assay and screened its proprietary library of approximately 20.000 distinct novel fragments.

This fragment screen revealed hits from a number of distinctive different chemotypes that specifically bound to the active site of the target protein. Each of these chemotypes has been validated and the binding mode was determined by crystallography to develop the most promising candidate for subsequent fragment evolution, lead finding and optimization.

“This first phase of the integrated drug discovery collaboration with the ability to utilize structure-guided SAR, has progressed very rapidly, yielding significant results and information that will facilitate the eventual identification of innovative, therapeutically valuable lead candidates for our pipeline”, said Nick Renaldo, President at Revitocrine

 

Contact Us

Please send us a message if you would like to invest or hear more


Revitocrine

600 West Broadway, Suite 1200 San Diego, California 92101, United States

Hours

Monday - Friday: 8:00am - 5:00pm

Saturday - Sunday: Closed

Send Message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Subscribe

Sign up to hear about our progress

Copyright © 2023 Revitocrine - All Rights Reserved.

Powered by GoDaddy